Almoosa Health Company (TADAWUL:4018)
Saudi Arabia
· Delayed Price · Currency is SAR
154.40
-2.60 (-1.66%)
Mar 6, 2025, 3:17 PM AST
Almoosa Health Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 94.42 | 98.15 | 51.02 | 62.42 | 104.77 |
| Depreciation & Amortization | - | 64.76 | 56.94 | 28.49 | 23.36 |
| Other Amortization | - | 3.53 | 2.65 | 1.46 | 1.58 |
| Loss (Gain) From Sale of Assets | - | -0.33 | -0.03 | 0.07 | -0 |
| Asset Writedown & Restructuring Costs | - | - | 0.01 | 0.01 | 0.55 |
| Provision & Write-off of Bad Debts | - | 3.93 | -0.17 | 1.22 | 0.15 |
| Other Operating Activities | 89.26 | 14.29 | 14.93 | 12.08 | -2 |
| Change in Accounts Receivable | - | -166.81 | -66.22 | -10.71 | -28.82 |
| Change in Inventory | - | -9.29 | -0.16 | -7.77 | -6.47 |
| Change in Accounts Payable | - | 3.15 | -49.76 | 75.25 | 80.92 |
| Change in Other Net Operating Assets | - | 28.7 | -20.19 | 35.21 | -24.13 |
| Operating Cash Flow | 183.68 | 40.07 | -10.97 | 197.72 | 149.92 |
| Operating Cash Flow Growth | 358.41% | - | - | 31.88% | - |
| Capital Expenditures | - | -383.19 | -307.18 | -318.47 | -436.81 |
| Sale of Property, Plant & Equipment | - | 23.07 | 0.03 | 0.02 | 0.04 |
| Sale (Purchase) of Intangibles | - | -2.16 | -2.89 | -0.31 | -1.12 |
| Investment in Securities | - | - | - | 3.28 | - |
| Other Investing Activities | -262.24 | - | - | - | - |
| Investing Cash Flow | -262.24 | -454.39 | -310.04 | -315.49 | -437.89 |
| Long-Term Debt Issued | - | 622.91 | 285.67 | 148.91 | 290.53 |
| Short-Term Debt Repaid | - | - | - | - | -1 |
| Long-Term Debt Repaid | - | -208 | -7.54 | -7.54 | -0.75 |
| Total Debt Repaid | - | -208 | -7.54 | -7.54 | -1.75 |
| Net Debt Issued (Repaid) | - | 414.92 | 278.13 | 141.38 | 288.78 |
| Issuance of Common Stock | - | - | - | - | 5 |
| Common Dividends Paid | - | - | - | -15.66 | - |
| Other Financing Activities | 100.92 | - | - | - | - |
| Financing Cash Flow | 100.92 | 414.92 | 278.13 | 125.71 | 293.78 |
| Net Cash Flow | 22.36 | 0.6 | -42.88 | 7.94 | 5.81 |
| Free Cash Flow | 183.68 | -343.12 | -318.15 | -120.76 | -286.89 |
| Free Cash Flow Margin | 15.28% | -35.05% | -38.99% | -17.21% | -45.61% |
| Free Cash Flow Per Share | 5.25 | -9.80 | -9.09 | -1207.55 | - |
| Cash Interest Paid | - | 24.02 | 10 | 1.14 | 1.44 |
| Levered Free Cash Flow | - | -370.96 | -359.89 | -122.63 | - |
| Unlevered Free Cash Flow | - | -355.45 | -351.6 | -121.7 | - |
| Change in Net Working Capital | - | 116.07 | 134.52 | -126.88 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.